newsfilter
← Latest News
ACCESS Newswire·

CNS Pharmaceuticals Announces Reverse Stock Split

HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the development of novel treatments